Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Women's Roles and Barriers to Leadership in the National Collegiate Athletic Association.

Sheehy AM, Miller P, Carnes M.

JAMA Intern Med. 2019 Nov 4. doi: 10.1001/jamainternmed.2019.5151. [Epub ahead of print] No abstract available.

PMID:
31682674
2.

Identifying Observation Stays In Medicare Data: Policy Implications of a Definition.

Sheehy AM, Shi F, Kind AJH.

J Hosp Med. 2019 Feb 1;14(2):96-100. doi: 10.12788/jhm.3038. Epub 2018 Aug 29.

PMID:
30156579
3.

In Reference to "The Weekend Effect in Hospitalized Patients: A Meta-Analysis".

Flansbaum B, Sheehy AM.

J Hosp Med. 2018 Jun 1;13(6):437. doi: 10.12788/jhm.2912. Epub 2018 Jan 22.

PMID:
29856887
4.

Impact of Observation Hospitalizations on Low-Income Medicare Beneficiaries.

Sheehy AM, Thompson L, Flansbaum B.

Am J Med. 2018 Feb;131(2):e67. doi: 10.1016/j.amjmed.2017.08.034. No abstract available.

PMID:
29362107
5.

The Search Continues for Optimal Intensive Care Unit Glucose Management and Measurement.

Long MT, Sheehy AM, Coursin DB.

Mayo Clin Proc. 2017 Jul;92(7):1011-1014. doi: 10.1016/j.mayocp.2017.05.014. Epub 2017 Jun 20. No abstract available.

PMID:
28645516
6.

Hospitalizations With Observation Services and the Medicare Part A Complex Appeals Process at Three Academic Medical Centers.

Sheehy AM, Engel JZ, Locke CFS, Weissburg DJ, Eldridge K, Caponi B, Deutschendorf A.

J Hosp Med. 2017 Apr;12(4):251-255. doi: 10.12788/jhm.2720.

PMID:
28411297
7.

Medicare and the 3-Inpatient Midnight Requirement: A Statute in Need of Modernization.

Sheehy AM, Courtney J.

J Hosp Med. 2017 Mar;12(3):199-200. doi: 10.12788/jhm.2707. No abstract available.

PMID:
28272600
8.

The Authors Reply I, "patient financial responsibility for observation care" and "observation versus inpatient hospitalization: What do medicare beneficiaries pay?".

Sheehy AM, Boswell J, Caponi B, Locke CF.

J Hosp Med. 2016 Jun;11(6):457-8. doi: 10.1002/jhm.2563. Epub 2016 Feb 23. No abstract available.

PMID:
26914412
9.

Observation versus inpatient hospitalization: What do Medicare beneficiaries pay?

Sheehy AM, Boswell J, Caponi B, Locke CF.

J Hosp Med. 2015 Nov;10(11):760-1. doi: 10.1002/jhm.2440. Epub 2015 Aug 20. No abstract available.

PMID:
26291040
10.

We specialize in change leadership: A call for hospitalists to lead the quest for workforce gender equity.

Sheehy AM, Kolehmainen C, Carnes M.

J Hosp Med. 2015 Aug;10(8):551-2. doi: 10.1002/jhm.2399. Epub 2015 Jun 30. No abstract available.

PMID:
26122268
11.

The Authors Reply: "Changes to inpatient versus outpatient hospitalization: Medicare's 2-midnight rule".

Locke C, Sheehy AM.

J Hosp Med. 2015 Aug;10(8):561. doi: 10.1002/jhm.2372. Epub 2015 Jun 19. No abstract available.

PMID:
26097201
12.

Recovery Audit Contractor audits and appeals at three academic medical centers.

Sheehy AM, Locke C, Engel JZ, Weissburg DJ, Mackowiak S, Caponi B, Gangireddy S, Deutschendorf A.

J Hosp Med. 2015 Apr;10(4):212-9. doi: 10.1002/jhm.2332. Epub 2015 Feb 24.

PMID:
25707363
13.

Changes to inpatient versus outpatient hospitalization: Medicare's 2-midnight rule.

Locke C, Sheehy AM, Deutschendorf A, Mackowiak S, Flansbaum BE, Petty B.

J Hosp Med. 2015 Mar;10(3):194-201. doi: 10.1002/jhm.2312. Epub 2014 Dec 31. Review.

PMID:
25557865
14.

The role of copy-and-paste in the hospital electronic health record.

Sheehy AM, Weissburg DJ, Dean SM.

JAMA Intern Med. 2014 Aug;174(8):1217-8. doi: 10.1001/jamainternmed.2014.2110. No abstract available.

PMID:
24887572
15.

Observation and inpatient status: clinical impact of the 2-midnight rule.

Sheehy AM, Caponi B, Gangireddy S, Hamedani AG, Pothof JJ, Siegal E, Graf BK.

J Hosp Med. 2014 Apr;9(4):203-9. doi: 10.1002/jhm.2163. Epub 2014 Feb 14.

PMID:
24677628
16.

Dedicated observation unit for patients with "observation status"--reply.

Sheehy AM.

JAMA Intern Med. 2014 Feb 1;174(2):301-2. doi: 10.1001/jamainternmed.2013.13477. No abstract available.

PMID:
24493606
17.

Antihypertensive medication initiation among young adults with regular primary care use.

Johnson HM, Thorpe CT, Bartels CM, Schumacher JR, Palta M, Pandhi N, Sheehy AM, Smith MA.

J Gen Intern Med. 2014 May;29(5):723-31. doi: 10.1007/s11606-014-2790-4. Epub 2014 Feb 4.

18.

Undiagnosed hypertension among young adults with regular primary care use.

Johnson HM, Thorpe CT, Bartels CM, Schumacher JR, Palta M, Pandhi N, Sheehy AM, Smith MA.

J Hypertens. 2014 Jan;32(1):65-74. doi: 10.1097/HJH.0000000000000008.

19.

"Observation status" for hospitalized patients: implications of a proposed Medicare rules change.

Sheehy AM, Graf BK, Gangireddy S, Formisano R, Jacobs EA.

JAMA Intern Med. 2013 Nov 25;173(21):2004-6. doi: 10.1001/jamainternmed.2013.9382. No abstract available.

PMID:
23978913
20.

Hospitalized but not admitted: characteristics of patients with "observation status" at an academic medical center.

Sheehy AM, Graf B, Gangireddy S, Hoffman R, Ehlenbach M, Heidke C, Fields S, Liegel B, Jacobs EA.

JAMA Intern Med. 2013 Nov 25;173(21):1991-8. doi: 10.1001/jamainternmed.2013.8185.

21.

Preoperative "NPO" as an opportunity for diabetes screening.

Sheehy AM, Benca J, Glinberg SL, Li Z, Nautiyal A, Anderson PA, Squire MW, Coursin DB.

J Hosp Med. 2012 Oct;7(8):611-6. doi: 10.1002/jhm.1958. Epub 2012 Aug 7.

PMID:
22887757
22.

APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans.

Sheehy AM, Erthal J.

Mol Biol Int. 2012;2012:974924. doi: 10.1155/2012/974924. Epub 2012 Jun 6.

23.

Building a diabetes screening population data repository using electronic medical records.

Tuan WJ, Sheehy AM, Smith MA.

J Diabetes Sci Technol. 2011 May 1;5(3):514-22.

24.

NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G.

Farrow MA, Kim EY, Wolinsky SM, Sheehy AM.

J Biol Chem. 2011 Jan 28;286(4):2567-77. doi: 10.1074/jbc.M110.154377. Epub 2010 Nov 15.

25.

Critical illness-induced dysglycaemia: diabetes and beyond.

Smith FG, Sheehy AM, Vincent JL, Coursin DB.

Crit Care. 2010;14(6):327. doi: 10.1186/cc9266. Epub 2010 Nov 5. Review.

26.

An overview of preoperative glucose evaluation, management, and perioperative impact.

Sheehy AM, Gabbay RA.

J Diabetes Sci Technol. 2009 Nov 1;3(6):1261-9. Review.

27.

Analysis of guidelines for screening diabetes mellitus in an ambulatory population.

Sheehy AM, Flood GE, Tuan WJ, Liou JI, Coursin DB, Smith MA.

Mayo Clin Proc. 2010 Jan;85(1):27-35. doi: 10.4065/mcp.2009.0289.

28.

Risks of tight glycemic control during adult cardiac surgery.

Sheehy AM, Coursin DB, Keegan MT.

Ann Thorac Surg. 2009 Oct;88(4):1384-5; author reply 1385-6. doi: 10.1016/j.athoracsur.2009.04.115. No abstract available.

PMID:
19766856
29.

Glucose control in the intensive care unit.

Fahy BG, Sheehy AM, Coursin DB.

Crit Care Med. 2009 May;37(5):1769-76. doi: 10.1097/CCM.0b013e3181a19ceb. Review.

PMID:
19325461
30.

Perioperative glucose control: what is enough?

Fahy BG, Sheehy AM, Coursin DB.

Anesthesiology. 2009 Feb;110(2):204-6. doi: 10.1097/ALN.0b013e3181948aae. No abstract available.

PMID:
19194142
31.

Back to Wilson and Jungner: 10 good reasons to screen for type 2 diabetes mellitus.

Sheehy AM, Coursin DB, Gabbay RA.

Mayo Clin Proc. 2009;84(1):38-42. doi: 10.1016/S0025-6196(11)60806-9. Review. No abstract available. Erratum in: Mayo Clin Proc. 2009 Feb;84(2):208.

32.

Hepatocellular carcinoma: failure to diagnose does not equal malpractice.

Sheehy GL, Sheehy AM.

Am J Med. 2008 Oct;121(10):e9; author reply e11-2. doi: 10.1016/j.amjmed.2008.04.036. No abstract available.

PMID:
18823846
33.

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.

Zabludoff SD, Deng C, Grondine MR, Sheehy AM, Ashwell S, Caleb BL, Green S, Haye HR, Horn CL, Janetka JW, Liu D, Mouchet E, Ready S, Rosenthal JL, Queva C, Schwartz GK, Taylor KJ, Tse AN, Walker GE, White AM.

Mol Cancer Ther. 2008 Sep;7(9):2955-66. doi: 10.1158/1535-7163.MCT-08-0492.

34.

Vif and Apobec3G in the innate immune response to HIV: a tale of two proteins.

Farrow MA, Sheehy AM.

Future Microbiol. 2008 Apr;3(2):145-54. doi: 10.2217/17460913.3.2.145. Review.

PMID:
18366335
35.

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.

Newman EN, Holmes RK, Craig HM, Klein KC, Lingappa JR, Malim MH, Sheehy AM.

Curr Biol. 2005 Jan 26;15(2):166-70.

36.

Further investigation of simian immunodeficiency virus Vif function in human cells.

Gaddis NC, Sheehy AM, Ahmad KM, Swanson CM, Bishop KN, Beer BE, Marx PA, Gao F, Bibollet-Ruche F, Hahn BH, Malim MH.

J Virol. 2004 Nov;78(21):12041-6.

37.

Cytidine deamination of retroviral DNA by diverse APOBEC proteins.

Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, Malim MH.

Curr Biol. 2004 Aug 10;14(15):1392-6.

38.

APOBEC-mediated editing of viral RNA.

Bishop KN, Holmes RK, Sheehy AM, Malim MH.

Science. 2004 Jul 30;305(5684):645.

39.

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Sheehy AM, Gaddis NC, Malim MH.

Nat Med. 2003 Nov;9(11):1404-7. Epub 2003 Oct 5.

40.

DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses.

Harris RS, Sheehy AM, Craig HM, Malim MH, Neuberger MS.

Nat Immunol. 2003 Jul;4(7):641-3. No abstract available.

PMID:
12830140
41.

DNA deamination mediates innate immunity to retroviral infection.

Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH.

Cell. 2003 Jun 13;113(6):803-9. Erratum in: Cell. 2004 Feb 20;116(4):629.

42.

Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.

Gaddis NC, Chertova E, Sheehy AM, Henderson LE, Malim MH.

J Virol. 2003 May;77(10):5810-20.

43.

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Sheehy AM, Gaddis NC, Choi JD, Malim MH.

Nature. 2002 Aug 8;418(6898):646-50. Epub 2002 Jul 14.

PMID:
12167863
44.

Overexpression of RelA causes G1 arrest and apoptosis in a pro-B cell line.

Sheehy AM, Schlissel MS.

J Biol Chem. 1999 Mar 26;274(13):8708-16.

45.

Mutational analysis of the human immunodeficiency virus type 1 Vif protein.

Simon JH, Sheehy AM, Carpenter EA, Fouchier RA, Malim MH.

J Virol. 1999 Apr;73(4):2675-81.

46.

Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide.

Sheehy AM, Burson MA, Black SM.

Am J Physiol. 1998 May;274(5):L833-41. doi: 10.1152/ajplung.1998.274.5.L833.

PMID:
9612300
47.

Growth factor induction of nitric oxide synthase in rat pheochromocytoma cells.

Sheehy AM, Phung YT, Riemer RK, Black SM.

Brain Res Mol Brain Res. 1997 Dec 1;52(1):71-7.

PMID:
9450679
48.

Intrapulmonary delivery of renin inhibitory peptides results in sustained release because of saturable transport.

Sheehy AM, Hoover JL, Rush BD, Wilkinson KF, Vidmar TJ, Ruwart MJ.

Pharm Res. 1993 Oct;10(10):1548-51. No abstract available.

PMID:
8272421
49.

Civil defense nursing activities in Connecticut.

SHEEHY AM.

Public Health Nurs. 1952 Mar;44(3):159. No abstract available.

PMID:
14912229

Supplemental Content

Loading ...
Support Center